川崎病患儿血清中hs-CRP与基质金属蛋白酶及抑制剂联合检测的临床意义

陈瑞; 张爱荣; 赵信喜; 李战华

PDF(1052 KB)

中国当代儿科杂志 ›› 2009, Vol. 11 ›› Issue (12) : 989-991.

论著·临床研究

川崎病患儿血清中hs-CRP与基质金属蛋白酶及抑制剂联合检测的临床意义

陈瑞，张爱荣，赵信喜，李战华

作者信息 +

Roles of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase and hs-CRP in Kawasaki disease

CHEN Rui, ZHANG Ai-Rong, ZHAO Xin-Xi, LI Zhan-Hua

Author information +

文章历史 +

摘要

目的：检测基质金属蛋白酶(MMP)-2、MMP-9、基质金属蛋白酶抑制剂(TIMP)-1及hs-CRP在川崎病患儿血清中的表达，并探讨其与冠状动脉损伤的关系。方法：选取151例川崎病患儿作为观察组（无冠状动脉损伤40例，有冠状动脉损伤111例），60例健康儿童作为对照组，采用酶联免疫吸附实验(ELISA)检测血清中MMP-2、MMP-9和TIMP-1含量，应用终点散射比浊法检测血清hs-CRP的含量。结果：MMP-2，MMP-9及hs-CRP含量在冠脉损伤组及无冠脉损伤组与对照组比较差异均有显著性，在冠脉损伤组量最高（P<0.05）；川崎病患儿中MMP-2、MMP-9及TIMP-1之间的检测量呈正相关（P<0.05）。结论：MMP-2、MMP-9、TIMP-1及hs-CRP在川崎病的发生发展中可能起重要作用，MMP-2、MMP-9及hs-CRP的联合检测可能对判断病变程度有重要帮助。［中国当代儿科杂志，2009，11（12）：989-991］

Abstract

OBJECTIVE: To examine the expression of matrix metalloproteinases (MMP)-2, -9, tissue inhibitor of matrix metalloproteinase (TIMP)-1 and hs-CRP, and their relationship with coronary artery in children with Kawasaki disease. METHODS: One hundred and fifty-one children with Kawasaki disease (111 cases with coronary artery damage and 40 cases without) and 60 healthy children were enrolled. The expression of MMP-2, MMP-9 and TIMP-1 was detected using ELISA, and the hs-CRP concentration was measured using the endpoint nephelometry. RESULTS: There were significant differences in the level of MMP-2, MMP-9 and hs-CRP between the patients with or without coronary artery damage and the healthy children (P<0.05). The levels of MMP-2, MMP-9 and hs-CRP were the highest in the cardiovascular damage group (P<0.05). There were positive correlations between MMP-2, MMP-9 and TIMP-1 in children with Kawasaki disease. CONCLUSIONS: MMP-2, MMP-9, TIMP-1 and hs-CRP may play important roles in the development of Kawasaki disease. The combined measurement of MMP-2, MMP-9 and hs-CRP may be useful in the evaluation of the severity in children with Kawasaki disease.［Chin J Contemp Pediatr, 2009, 11 (12):989-991］

导出引用

陈瑞, 张爱荣, 赵信喜, 李战华. 川崎病患儿血清中hs-CRP与基质金属蛋白酶及抑制剂联合检测的临床意义[J]. 中国当代儿科杂志. 2009, 11(12): 989-991

CHEN Rui, ZHANG Ai-Rong, ZHAO Xin-Xi, LI Zhan-Hua. Roles of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase and hs-CRP in Kawasaki disease[J]. Chinese Journal of Contemporary Pediatrics. 2009, 11(12): 989-991

中图分类号： R725

参考文献

［1］杜忠东, 于淼. 小儿川崎病的临床诊断标准［J］. 中国临床医生, 2001, 29(3):30-31.
［2］黄培. 川崎病患儿血清基质金属蛋白酶-1表达的意义［J］. 实用儿科临床杂志, 2007, 22(21):1634-1635.
［3］Hung J, Knuiman MW, Divitini ML, Langton PE, Chapman CL, Beilby JP. C-reactive protein and interleukin-18 levels in relation to coronary heart disease: prospective cohort study from Busselton Western Australia［J］. Heart Lung Circ, 2008, 17(2):90-95.
［4］刘爱东, 庞久玲, 刘士生. 胃癌中基质金属蛋白酶-9和CD105表达关系的研究［J］. 中国老年学杂志, 2009, 29(7):886-887.
［5］尹红, 殷思纯, 刘颖, 罗北京, 王玉博. MCP-1, CRP, MMP-2和TIMP-2在川崎病患儿血清中的表达及其意义［J］. 广东医学, 2006, 27(5):688-670.
［6］Senzaki H. The pathophysiology of coronary atery aneurysms in Kawasaki disease: role of matrix metalloproteinases［J］. Arch Dis Child, 2006, 91(10):847-851.
［7］洪华, 邓君, 彭莤, 梁敏, 张玲英. 川崎病患儿血清MMP-9和TIMP-1的水平测定［J］. 江西医学检验, 2005, 23(2):107-109.
［8］Chua PK, Melish ME, Yu Q, Yanaqihara R, Yamamoto KS, Nerurkar VR. Elevated levels of metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 during the acute phase of Kawasake disease［J］. Clin Diagn Lab Immunol, 2003, 10(2):308-314.
［9］杨世伟, 王大为, 秦玉明, 李军, 王凤鸣, 左维嵩. 基质金属蛋白酶-9在川崎病外周血表达及其在冠状动脉损伤中的临床意义［J］. 南京医科大学学报(自然科学版), 2005, 25(2):87-90.
［10］Gavin PJ, Crawford SE, Shulman ST, Garcia FL, Rowlev AH. Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease［J］. Arterioscler Thromb Vasc Biol, 2003, 23(4):576-581.
［11］彭莤, 吴青, 陈昌辉, 洪华, 张玲英. 血清s-2R、IL-6与hs-CRP水平的测定在川崎病早期诊断中的临床意义［J］. 中国当代儿科杂志, 2006, 8(3):208-210.